Making stable, early-stage human stem cells for better disease models and therapies
Resolving epigenetic instability during pluripotent state transitions: a roadmap for exploiting the biomedical potential of dynamic human stem cell states
Researchers are developing more stable human stem cells that behave like early embryo cells to improve how we study development and disease and to support future therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11321092 on NIH RePORTER |
What this research studies
If you or a loved one might benefit from better lab models of human development, this project works with human pluripotent stem cell lines to recreate a ‘naïve’ early embryo-like state. The team will map and fix epigenetic problems—such as DNA methylation and imprinting loss—that make these cells unstable. They will test different culture conditions and molecular interventions in the lab to keep the cells developmentally faithful and responsive to signals. The goal is to create a reliable cell platform that researchers can use for studying disease and for developing safer cell-based treatments.
Who could benefit from this research
Good fit: This is laboratory research that does not enroll patients, but people with developmental disorders or conditions that might one day need cell therapies could benefit from the improved models produced by this work.
Not a fit: Patients looking for immediate treatments or clinical trial enrollment would not benefit directly now because the work is preclinical and lab-based.
Why it matters
Potential benefit: If successful, this work could produce more reliable human stem cells for studying developmental disorders, testing drugs, and developing regenerative therapies.
How similar studies have performed: Previous research has shown that primed stem cells can be converted to naïve-like states, but persistent epigenetic instability is a known problem, so this project builds on prior progress while tackling unresolved issues.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Theunissen, Thorold — Washington University
- Study coordinator: Theunissen, Thorold
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.